Laurion Capital Management LP Wave Life Sciences Ltd. Transaction History

Laurion Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.38 - $6.48 $1.56 Million - $2.3 Million	-355,027 Reduced 40.74%	516,473 $2.58 Million
Q1 2024 May 15, 2024	SELL	$3.54 - $6.84 $708,000 - $1.37 Million	-200,000 Reduced 18.67%	871,500 $5.38 Million
Q4 2023 Feb 14, 2024	BUY	$4.16 - $6.87 $1.01 Million - $1.67 Million	242,662 Added 29.28%	1,071,500 $5.41 Million
Q2 2023 Aug 14, 2023	SELL	$3.51 - $4.69 $149,743 - $200,084	-42,662 Reduced 4.9%	828,838 $3.02 Million
Q2 2022 Aug 15, 2022	BUY	$1.23 - $3.25 $1.07 Million - $2.83 Million	871,500 New	871,500 $2.83 Million

164

117M

148K

109K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.25B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.